183 related articles for article (PubMed ID: 23792966)
41. Investigation of the mechanism of interaction between Mannose-binding lectin-associated serine protease-2 and complement C4.
Drentin N; Conroy P; Gunzburg MJ; Pike RN; Wijeyewickrema LC
Mol Immunol; 2015 Oct; 67(2 Pt B):287-93. PubMed ID: 26130224
[TBL] [Abstract][Full Text] [Related]
42. The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions.
Harmat V; Gál P; Kardos J; Szilágyi K; Ambrus G; Végh B; Náray-Szabó G; Závodszky P
J Mol Biol; 2004 Oct; 342(5):1533-46. PubMed ID: 15364579
[TBL] [Abstract][Full Text] [Related]
43. A novel COLEC10 mutation in a child with 3MC syndrome.
Migliorero M; Kalantari S; Bracciamà V; Sorbini M; Arruga F; Peruzzi L; Biamino E; Amoroso A; Vaisitti T; Deaglio S
Eur J Med Genet; 2021 Dec; 64(12):104374. PubMed ID: 34740859
[TBL] [Abstract][Full Text] [Related]
44. Serum MASP-1 in complex with MBL activates endothelial cells.
Megyeri M; Jani PK; Kajdácsi E; Dobó J; Schwaner E; Major B; Rigó J; Závodszky P; Thiel S; Cervenak L; Gál P
Mol Immunol; 2014 May; 59(1):39-45. PubMed ID: 24472859
[TBL] [Abstract][Full Text] [Related]
45. The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway.
Iwaki D; Kanno K; Takahashi M; Endo Y; Matsushita M; Fujita T
J Immunol; 2011 Oct; 187(7):3751-8. PubMed ID: 21865552
[TBL] [Abstract][Full Text] [Related]
46. Toward a structure-based comprehension of the lectin pathway of complement.
Kjaer TR; Thiel S; Andersen GR
Mol Immunol; 2013 Dec; 56(4):413-22. PubMed ID: 23911397
[TBL] [Abstract][Full Text] [Related]
47. MASP1 (MBL-associated serine protease 1).
Matsushita M; Endo Y; Fujita T
Immunobiology; 1998 Aug; 199(2):340-7. PubMed ID: 9777417
[TBL] [Abstract][Full Text] [Related]
48. Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors.
Szakács D; Kocsis A; Szász R; Gál P; Pál G
J Biol Chem; 2019 May; 294(20):8227-8237. PubMed ID: 30952698
[TBL] [Abstract][Full Text] [Related]
49. Asymmetrical skull, ptosis, hypertelorism, high nasal bridge, clefting, umbilical anomalies, and skeletal anomalies in sibs: is Carnevale syndrome a separate entity?
Al Kaissi A; Klaushofer K; Safi H; Chehida FB; Ghachem MB; Chaabounni M; Hennekam RC
Am J Med Genet A; 2007 Feb; 143(4):349-54. PubMed ID: 17236195
[TBL] [Abstract][Full Text] [Related]
50. Functional characterization of complement proteases C1s/mannan-binding lectin-associated serine protease-2 (MASP-2) chimeras reveals the higher C4 recognition efficacy of the MASP-2 complement control protein modules.
Rossi V; Teillet F; Thielens NM; Bally I; Arlaud GJ
J Biol Chem; 2005 Dec; 280(51):41811-8. PubMed ID: 16227207
[TBL] [Abstract][Full Text] [Related]
51. Toward a structure-based comprehension of the lectin pathway of complement.
Kjaer TR; Thiel S; Andersen GR
Mol Immunol; 2013 Dec; 56(3):222-31. PubMed ID: 23810291
[TBL] [Abstract][Full Text] [Related]
52. Dissociation and re-association studies on the interaction domains of mannan-binding lectin (MBL)-associated serine proteases, MASP-1 and MASP-2, provide evidence for heterodimer formation.
Paréj K; Hermann A; Donáth N; Závodszky P; Gál P; Dobó J
Mol Immunol; 2014 May; 59(1):1-9. PubMed ID: 24424083
[TBL] [Abstract][Full Text] [Related]
53. Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism.
Oroszlán G; Dani R; Szilágyi A; Závodszky P; Thiel S; Gál P; Dobó J
Front Immunol; 2017; 8():1821. PubMed ID: 29326707
[TBL] [Abstract][Full Text] [Related]
54. Mannose-binding lectin serine proteases and associated proteins of the lectin pathway of complement: two genes, five proteins and many functions?
Yongqing T; Drentin N; Duncan RC; Wijeyewickrema LC; Pike RN
Biochim Biophys Acta; 2012 Jan; 1824(1):253-62. PubMed ID: 21664989
[TBL] [Abstract][Full Text] [Related]
55. Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity.
Thiel S; Kolev M; Degn S; Steffensen R; Hansen AG; Ruseva M; Jensenius JC
J Immunol; 2009 Mar; 182(5):2939-47. PubMed ID: 19234189
[TBL] [Abstract][Full Text] [Related]
56. A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation.
Skjoedt MO; Hummelshoj T; Palarasah Y; Honore C; Koch C; Skjodt K; Garred P
J Biol Chem; 2010 Mar; 285(11):8234-43. PubMed ID: 20053996
[TBL] [Abstract][Full Text] [Related]
57. Crystal structure of the CUB1-EGF-CUB2 domain of human MASP-1/3 and identification of its interaction sites with mannan-binding lectin and ficolins.
Teillet F; Gaboriaud C; Lacroix M; Martin L; Arlaud GJ; Thielens NM
J Biol Chem; 2008 Sep; 283(37):25715-25724. PubMed ID: 18596036
[TBL] [Abstract][Full Text] [Related]
58. Factor D.
Sekine H; Machida T; Fujita T
Immunol Rev; 2023 Jan; 313(1):15-24. PubMed ID: 36316810
[TBL] [Abstract][Full Text] [Related]
59. Mannan-binding-lectin-associated serine proteases, characteristics and disease associations.
Sørensen R; Thiel S; Jensenius JC
Springer Semin Immunopathol; 2005 Nov; 27(3):299-319. PubMed ID: 16189649
[TBL] [Abstract][Full Text] [Related]
60. Recombinant expression of the autocatalytic complement protease MASP-1 is crucially dependent on co-expression with its inhibitor, C1 inhibitor.
Degn SE; Thiel S; Jensenius JC
Protein Expr Purif; 2013 Apr; 88(2):173-82. PubMed ID: 23314348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
